Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
13,929,616
-
Share change
-
+40,112
-
Total reported value
-
$76,086,979
-
Price per share
-
$5.50
-
Number of holders
-
18
-
Value change
-
+$219,855
-
Number of buys
-
6
-
Number of sells
-
2
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2019
As of 31 Dec 2019,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,929,616 shares.
The largest 10 holders included
Blackstone Group Inc, BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, Omega Fund Management, LLC, Soleus Capital Management, L.P., ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., DRW Securities, LLC, COMMONWEALTH EQUITY SERVICES, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.